Novel inhibitor combinations and susceptibility tests offer upper hand in the AMR arms race
Dr. Nathan Ledeboer highlights how new antimicrobial combos and accurate susceptibility testing are helping fight against AMR
Editor's picks
Accelerating Science
See how scientists are unlocking the secrets behind disease with multiomics, NGS, organoids, liquid biopsies, and more
Explore topics
Clinical Diagnostics
The global #CLINICAL24 2025 conversation has begun! Tell us your daily challenges and let's explore the solutions together
Explore topics
Environmental
Explore the science, regulations, and analytical strategies shaping the global response to PFAS contamination
Explore topics
